Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

por Mancinelli, Chiara Rosa, Rossi, Nicola De, Capra, Ruggero
Publicado 2021

Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection

por Chiarini, Marco, Paghera, Simone, Moratto, Daniele, Rossi, Nicola De, Giacomelli, Mauro, Badolato, Raffaele, Capra, Ruggero, Imberti, Luisa
Publicado 2020